KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Castle Biosciences (CSTL) Other Gross PP&E Adjustments (2018 - 2025)

Historic Other Gross PP&E Adjustments for Castle Biosciences (CSTL) over the last 8 years, with Q3 2025 value amounting to $86.6 million.

  • Castle Biosciences' Other Gross PP&E Adjustments rose 9696.27% to $86.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $86.6 million, marking a year-over-year increase of 9696.27%. This contributed to the annual value of $47.2 million for FY2024, which is 18084.06% up from last year.
  • Latest data reveals that Castle Biosciences reported Other Gross PP&E Adjustments of $86.6 million as of Q3 2025, which was up 9696.27% from $74.1 million recorded in Q2 2025.
  • In the past 5 years, Castle Biosciences' Other Gross PP&E Adjustments registered a high of $86.6 million during Q3 2025, and its lowest value of $421000.0 during Q1 2022.
  • Its 5-year average for Other Gross PP&E Adjustments is $25.9 million, with a median of $15.3 million in 2023.
  • In the last 5 years, Castle Biosciences' Other Gross PP&E Adjustments tumbled by 9564.5% in 2022 and then surged by 284014.25% in 2023.
  • Quarter analysis of 5 years shows Castle Biosciences' Other Gross PP&E Adjustments stood at $3.0 million in 2021, then surged by 85.7% to $5.5 million in 2022, then soared by 206.24% to $16.8 million in 2023, then skyrocketed by 180.84% to $47.2 million in 2024, then soared by 83.25% to $86.6 million in 2025.
  • Its Other Gross PP&E Adjustments stands at $86.6 million for Q3 2025, versus $74.1 million for Q2 2025 and $58.5 million for Q1 2025.